Table 1 The baseline demographic, clinical, and laboratory parameters of the enrolled subjects.
PD (n = 32) | Control (n = 28) | p-value | |||
---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
Age | 64.31 | 8.49 | 66.18 | 12.75 | NS |
Gender (male/female) | 13/19 | 8/20 | NS | ||
Disease duration (month) | 13.03 | 10.63 | |||
UPDRS part 3 | 22.66 | 6.20 | |||
Modified H &Y | 1.59 | 0.53 | |||
PD Subtypes (TD/Mixed/AR) | 11/16/6 | ||||
NMSS | 28.84 | 15.60 | |||
BDI | 7.06 | 6.29 | 5.86 | 7.08 | NS |
MoCA-K | 25.03 | 1.94 | 25.64 | 2.02 | NS |
Lab parameters (serum) | |||||
Hb/Haematocrit | 12.93/39.46 | 1.79/4.43 | 13.16/39.45 | 1.19/3.34 | NS/NS |
BUN/Creatinine | 14.96/0.95 | 3.89/0.19 | 15.05/0.90 | 4.12/0.15 | NS/NS |
AST/ALT | 21.28/21.56 | 7.40/14.37 | 22.74/18.42 | 7.10/10.92 | NS/NS |
Lab parameters (CSF) | |||||
Alpha-synuclein (pg/mL) | 116.76 | 34.25 | 176.60 | 50.61 | <0.01 |
Total Tau (pg/mL) | 76.87 | 33.53 | 104.71 | 47.72 | <0.05 |
Phosphorylated tau (pg/mL) | 8.80 | 5.46 | 9.81 | 8.55 | NS |
Tau ratio | 0.18 | 0.14 | 0.14 | 0.16 | NS |
FP-CIT PET analysis | |||||
Left caudate | 3.48 | 0.94 | 5.58 | 0.85 | <0.01 |
Left putamen | 3.73 | 0.99 | 4.57 | 1.06 | <0.01 |
Right caudate | 3.48 | 1.05 | 4.69 | 0.92 | <0.01 |
Right putamen | 3.51 | 1.08 | 4.57 | 1.06 | <0.01 |
AI, caudate | 7.67 | 7.47 | 2.87 | 6.68 | <0.05 |
AI, putamen | 13.75 | 13.81 | 3.02 | 2.44 | <0.01 |